Indications and uses
Relieves acid indigestion heartburn sour stomach upset stomach associated with these symptoms
Relieves acid indigestion heartburn sour stomach upset stomach associated with these symptoms
do not use the maximum dosage for more than 2 weeks dissolve tablets completely in water prior to use 325mg, adults 60 years of age and over: 2-8 tablets every 4 hours, not more than 24 tablets in 24 hours adults under 60 years of age: 2-8 tablets every 4 hours, not more than 48 tablets in 24 hours 650mg, adults 60 years of age and over: 1-2 tablets every 4 hours, not more than 12 tablets in 24 hours adults under ...
SODIUM BICARBONATE - sodium bicarbonate tablet
Marlex Pharmaceuticals, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA; however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Sodium Bicarbonate
Sodium bicarbonate 10 gr (650 mg)
Sodium bicarbonate 5gr (325 mg)
Antacid
Relieves
a sodium restricted diet
taking a prescription drug. Antacids may interact with certain prescription drugs.
symptoms last more than 2 weeks
ask a health professional before use.
325mg,
650mg,
sodium 178 mg (650mg)
Pregelatinized starch, NF and mineral oil, USP
Call toll free 1-888-266-8818
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
| Count | 650 mg |
| 60 | 71610-445-53 |
| 90 | 71610-445-60 |
| 180 | 71610-445-80 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20200723JH
NDC 71610-445 - Sodium Bicarbonate 650 mg Tablets
| Class | Version | Type | Effective |
|---|---|---|---|
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71610-445-53 | 2023-01-30 | C162847 | 48780-1 | f386c649-fde1-0266-e053-dadaa90a7c1a | Sodium Bicarbonate Tablets |
| 71610-445-60 | 2023-01-30 | C162847 | 48780-1 | f386c649-fde1-0266-e053-dadaa90a7c1a | Sodium Bicarbonate Tablets |
| 71610-445-80 | 2023-01-30 | C162847 | 48780-1 | f386c649-fde1-0266-e053-dadaa90a7c1a | Sodium Bicarbonate Tablets |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71610-445-53 | Sodium Bicarbonate | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 71610-445-60 | Sodium Bicarbonate | 90 in 1 BOTTLE | TABLET | 90 | 1 | |
| 71610-445-80 | Sodium Bicarbonate | 180 in 1 BOTTLE | TABLET | 180 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71610-445-53 | EA - Each | 71610-445 | 729ef9fd-4c31-4d4f-8b92-2b52161b7c11 | 1 | 2021-11-09 |
| 71610-445-60 | EA - Each | 71610-445 | aef4e80f-9580-4e53-ac71-2f772761b279 | 1 | 2020-09-14 |
| 71610-445-80 | EA - Each | 71610-445 | 00147962-11db-4ad8-ae6f-9c2d2e00fd07 | 1 | 2020-09-14 |
| 10135-685-10 | EA - Each | 10135-685 | 6172b655-c454-470b-a1e0-27827801de54 | 1 | 2020-04-20 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71610-445 | 71610-445-53, 71610-445-60, 71610-445-80 |
| 10135-685 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM BICARBONATE | 8MDF5V39QO | ACTIB |
| STARCH, CORN | O8232NY3SJ | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 18daabfe-0f66-436b-bb87-d8694d00767b | 2928c7d3-1bcf-49cf-af9f-baabf4f7da27 | 2020-07-23 | Warnings | 18daabfe-0f66-436b-bb87-d8694d00767b 2928c7d3-1bcf-49cf-af9f-baabf4f7da27 |
Adverse event summaries are temporarily unavailable. Other product information remains available.